APA (7th ed.) Citation

Shapiro, A., Pasi, J., Mahlangu, J., Perry, D. J., Powell, J. S., Ragni, M. V., . . . Allen, G. (2013). Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study. Blood, 122(21), 2350. https://doi.org/10.1182/blood.V122.21.2350.2350

Chicago Style (17th ed.) Citation

Shapiro, Amy, et al. "Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study." Blood 122, no. 21 (2013): 2350. https://doi.org/10.1182/blood.V122.21.2350.2350.

MLA (9th ed.) Citation

Shapiro, Amy, et al. "Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study." Blood, vol. 122, no. 21, 2013, p. 2350, https://doi.org/10.1182/blood.V122.21.2350.2350.